Report Highlights
The global market for surgical equipment reached $4.1 billion in 2012. This is expected to increase to $5 billion in 2013 and about $8.2 billion by the end of 2018, with a compound annual growth rate (CAGR) of 10.3% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the global market for surgical equipment, which is undergoing significant changes with technology innovations such as surgical robotics, the introduction of powered surgical tools, and a significant focus on minimally invasive procedures.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period of 2013 to 2018.
- A breakdown of general, OB-GYN, arthroscopy, laparoscopy, and other categories of surgical instruments.
- Discussion of the market by supply chain, technology, geography, and by usability of equipment, such as disposable and reusable.
- Examination of the competitive landscape, focusing on mergers and acquisition, partnerships and collaborations, new product launches and innovations, and other developments.
SCOPE OF THE REPORT
This research report presents an in-depth analysis of the surgical equipment market, including forecasted trends and sales through 2018. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed in the report. The report discusses various supply chain participants such as manufacturers, suppliers, retailers and hospitals. Key trends, market estimates, significant strategies among the stakeholders, product portfolios and recent developments will be presented in detail. An in-depth patent analysis is presented in the report and focuses on the development of extensive technological trends across regions (i.e., the U.S., Europe and Japan).
The report presents a market analysis and estimates for the broad range of surgical equipment across the key therapeutic segments such as cardiovascular, neurology, gynecology and urology orthopedics. It excludes supporting devices such as anesthesia systems, sterilization equipment, diagnostic systems, integrated robotic systems and implants.
ANALYST CREDENTIALS
Bhavna Joshi has more than six years of experience researching and reporting on health care markets. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. After earning her MBA (marketing and finance stream) from Chennai University, she worked with major market research firms.
Bhavna Joshi has authored several market research studies on the health care sector. Some of these include:
- Health care tracking technologies.
- Molecular diagnostics market.
- High-growth markets in health care and life sciences.
- Adoption rates and analysis of OTC diabetic medicines and supplements.
- Radio-frequency identification (RFID), real time locating systems (RTLS), IP surveillance and other emerging technologies in health care.
Related Reports
Medical Robotics and Computer-Assisted Surgery: The Global Market
The global MRCAS market was valued at nearly $2.2 billion in 2011 and should reach nearly $2.4 billion in 2012. Total market value is expected to reach nearly $4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 10.6%.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More